Anaplastic Lymphoma Kinase-positive
Oncology·MeSH: Lung Neoplasms
Prevalence
56.0 / 100K
Incidence
19.6 / 100K/yr
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target Anaplastic Lymphoma Kinase-positive?
There are 1 clinical trial targeting Anaplastic Lymphoma Kinase-positive tracked by BioSniper.
What is the prevalence of Anaplastic Lymphoma Kinase-positive?
The estimated prevalence of Anaplastic Lymphoma Kinase-positive is approximately 56.0 per 100,000 population.
Deep-dive into Anaplastic Lymphoma Kinase-positive
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis